---
title: "Huadong Medicine's Unit Gets Nod for Supplementary Application for Imported Drug"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266299971.md"
description: "Huadong Medicine's Unit Gets Nod for Supplementary Application for Imported Drug"
datetime: "2025-11-18T04:20:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266299971.md)
  - [en](https://longbridge.com/en/news/266299971.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266299971.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/266299971.md) | [繁體中文](https://longbridge.com/zh-HK/news/266299971.md)


# Huadong Medicine's Unit Gets Nod for Supplementary Application for Imported Drug



### Related Stocks

- [HUADONG MEDICINE (000963.CN)](https://longbridge.com/en/quote/000963.CN.md)

## Related News & Research

- [Huadong Medicine's Unit Gets Nod for Hypertriglyceridemia Drug Clinical Trial](https://longbridge.com/en/news/274912733.md)
- [Huadong Medicine Gets U.S. Regulatory Nod for Liver Disease Drug Trial](https://longbridge.com/en/news/272634618.md)
- [Huadong Medicine's Two Drugs Placed in China's Insurance Drug List](https://longbridge.com/en/news/268897142.md)
- [Grand Pharmaceutical Says Imaging Agent Accepted For Chinese Regulatory Review](https://longbridge.com/en/news/272962693.md)
- [Huadong Medicine Q3 net profit up 7.7% y/y](https://longbridge.com/en/news/262877878.md)